Literature DB >> 6259672

The benzodiazepine receptor. An update.

W E Müller.   

Abstract

A short update about the data accumulated so far on the brain-specific binding sites of the benzodiazepines is the subject of this paper. Today, a large variety of biochemical and pharmacological data clearly indicates that these benzodiazepine receptors are the endogenous targets which mediate the pharmacological effects of the benzodiazepines. Furthermore, considerable evidence suggests that the benzodiazepine receptor serves as an amplifying system for GABAergic transmission by increasing the affinity of the GABA receptor. Since the physiological function of this receptor and its endogenous ligand are not yet known, one of the major topics of future research will be to finally identify the endogenous ligand(s) of the benzodiazepine receptor.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6259672     DOI: 10.1159/000137485

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  4 in total

1.  Beta-carboline binding indicates the presence of benzodiazepine receptor subclasses in the bovine central nervous system.

Authors:  K J Fehske; I Zube; H O Borbe; U Wollert; W E Müller
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-05       Impact factor: 3.000

2.  Determinants of benzodiazepine brain uptake: lipophilicity versus binding affinity.

Authors:  R M Arendt; D J Greenblatt; D C Liebisch; M D Luu; S M Paul
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

3.  Peripheral benzodiazepine binding sites on striated muscles of the rat: properties and effect of denervation.

Authors:  W E Müller; A Ickstadt; H C Hopf
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

4.  GABAB receptor-mediated inhibition of serotonin release in the rat brain.

Authors:  E Schlicker; K Classen; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-06       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.